Case series:pyrotinib

2 trials

Sponsors

Zhejiang Cancer Hospital, Jiangsu Cancer Hospital

Conditions

Lung Cancerbreast cancer

Phase 2

A multicenter study for pyrotinib maleate in the treatment of advanced non-small cell lung adenocarcinoma with HER2 mutation

Active, not recruitingChiCTR1800020262

Zhejiang Cancer HospitalLung Cancer

Start: 2019-01-02Updated: 2019-01-14

Phase 4

A real-world clinical study of pyrotinib maleate tablets in the treatment of her-2 positive breast cancer patients

Active, not recruitingChiCTR1900021819

Jiangsu Cancer Hospitalbreast cancer

Start: 2019-03-10Updated: 2019-03-18

Related Papers

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

2022-02-0152 citations

Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial

Clinical Cancer Research2021-11-0950 citations

Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real-world study.

Journal of Clinical Oncology2021-05-20